About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
Stage 4 Lung Adenocarcinoma and Brain Mets: Multidisciplinary Tumor Board Case Discussion
By
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
FEATURING
Adrienne Boire
,
Joshua Budhu
,
Brandon Imber
,
Nelson Moss
,
Andrew Seidman
,
Robert Young
,
Mark Kris
By
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
FEATURING
Adrienne Boire
,
Joshua Budhu
,
Brandon Imber
,
Nelson Moss
,
Andrew Seidman
,
Robert Young
,
Mark Kris
0 views
May 4, 2024
Comments
0
Login to view comments.
Click here to Login
Recommended
AUTOPLAY
ON
Related
Newest
16:02
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024
cfDNA for Liquid Biopsy for Patients With Glioblastoma
Feat.
S. Bagley
18:47
Total Health
Updates in the Management of NSCLC: Systemic Therapy Year in Review
Feat.
W. Iams
36:14
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …
Feat.
B. Halmos
17:33
Henry Friedman
Overview and Updates in Brain Tumors
17:34
ecancer
Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…
Feat.
L. Raez
13:23
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "A Pooled Analysis of T-DXd for HER2+ mBC Wi…
Feat.
S. Hurvitz
18:09
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
The Changing Prognosis of Lung Cancer Brain Metastases
Feat.
S. Goldberg
20:09
Penn Medicine's 11th Neuro-Oncology Brain Tumor Symposium 2024
Medical and Symptom Management of Patients With Brain Tumors
Feat.
A. Pruitt
17:25
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Breast Cancer Brain Metastases: From a Medical Oncologist’s Perspect…
Feat.
R. Dent
08:21
Total Health
Systemic Therapy for HER2+ CNS Disease: Management of Breast Cancer …
Feat.
C. Santa-Maria
04:42
Scripps Health
2024 Neuro-Oncology Update: Breast Cancer and Brain Mets
Feat.
T. McGranahan
17:07
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Melanoma Brain Metastases: Successes, Failures, and Future Opportuni…
Feat.
M. Postow
20:28
OncoAlert
mNSCLC Updates: 1L EGFRm, 2/3L EGFRm & Anti-Trop2 ADC
Feat.
C. Aggarwal
17:48
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Frontiers in Breast Cancer Brain Metastasis: ADC Effectiveness in th…
Feat.
S. Modi
12:26
Scripps Health
2024 Neuro-Oncology Update: NSCLC and Brain Mets
Feat.
T. McGranahan
34:50
Dana-Farber Cancer Institute
Surgical Approaches for Brain Tumors
Feat.
W. Linda Bi,
O. Arnaout
07:38
GRACE
How Does PD-L1 Score Affect Treatment Options for NSCLC
Feat.
S. Patel,
T. Leal,
P. Iyengar,
A. Desai,
C. Kim,
J. Rotow
20:19
MSKCC 2nd Annual Symposium on Advanced Therapeutics for Brain Metastasis
Chemoprevention in Brain Mets: Breast Cancer Perspective
Feat.
A. Zimmer
20:16
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Immunotherapy & Beyond - Advances in S…
Feat.
H. Tawbi
20:10
Insights from 2023 ESMO Annual Meeting
Systemic Therapy of CNS Disease in HER2+ BC
Feat.
S. Lee
